BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
Details
- Status
- Prescription
- First Approved
- 2009-07-31
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
Companies
BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE Approval History
What BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE Treats
9 indicationsBETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE is approved for 9 conditions since its original approval in 2009. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Asthma
- Atopic Dermatitis
- Contact Dermatitis
- Drug Hypersensitivity
- Allergic Rhinitis
- Serum Sickness
- Transfusion Reaction
- Exfoliative Erythroderma
Drugs Similar to BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE FDA Label Details
ProIndications & Usage
When oral therapy is not feasible, the intramuscular use of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated as follows: Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stev...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.